Show simple item record

dc.contributor.authorNachamkin, Irving
dc.contributor.authorShadomy, Sean V.
dc.contributor.authorMoran, Anthony P.
dc.contributor.authorCox, Nancy
dc.contributor.authorFitzgerald, Collette
dc.contributor.authorUng, Huong
dc.contributor.authorCorcoran, Adrian T.
dc.contributor.authorIskander, John K.
dc.contributor.authorSchonberger, Lawrence B.
dc.contributor.authorChen, Robert T.
dc.date.accessioned2018-09-20T16:18:58Z
dc.date.available2018-09-20T16:18:58Z
dc.date.issued2008-07-15
dc.identifier.citationNachamkin, Irving; Shadomy, Sean V. Moran, Anthony P.; Cox, Nancy; Fitzgerald, Collette; Ung, Huong; Corcoran, Adrian T.; Iskander, John K.; Schonberger, Lawrence B.; Chen, Robert T. (2008). Anti‐ganglioside antibody induction by swine (a/nj/1976/h1n1) and other influenza vaccines: insights into vaccine‐associated guillain‐barré syndrome. The Journal of Infectious Diseases 198 (2), 226-233
dc.identifier.issn0022-1899,1537-6613
dc.identifier.urihttp://hdl.handle.net/10379/13073
dc.description.abstractBackground. Receipt of an A/NJ/1976/H1N1 "swine flu" vaccine in 1976, unlike receipt of influenza vaccines used in subsequent years, was strongly associated with the development of the neurologic disorder Guillain-Barre syndrome (GBS). Anti-ganglioside antibodies (e. g., anti-GM(1)) are associated with the development of GBS, and we hypothesized that the swine flu vaccine contained contaminating moieties (such as Campylobacter jejuni antigens that mimic human gangliosides or other vaccine components) that elicited an anti-GM(1) antibody response in susceptible recipients. Methods. Surviving samples of monovalent and bivalent 1976 vaccine, comprising those from 3 manufacturers and 11 lot numbers, along with several contemporary vaccines were tested for hemagglutinin ( HA) activity, the presence of Campylobacter DNA, and the ability to induce anti-Campylobacter and anti-GM(1) antibodies after inoculation into C3H/HeN mice. Results. We found that, although C. jejuni was not detected in 1976 swine flu vaccines, these vaccines induced anti-GM(1) antibodies in mice, as did vaccines from 1991-1992 and 2004-2005. Preliminary studies suggest that the influenza HA induces anti-GM(1) antibodies. Conclusions. Influenza vaccines contain structures that can induce anti-GM(1) antibodies after inoculation into mice. Further research into influenza vaccine components that elicit anti-ganglioside responses and the role played by these antibodies (if any) in vaccine-associated GBS is warranted.
dc.publisherOxford University Press (OUP)
dc.relation.ispartofThe Journal of Infectious Diseases
dc.subjectcampylobacter-jejuni strains
dc.subjectunited-states
dc.subjectcross-reactivities
dc.subjectmolecular mimicry
dc.subjectganglioside gm1
dc.subjectlipopolysaccharides
dc.subjecthemagglutinin
dc.subjectinfections
dc.subjectviruses
dc.subjectforms
dc.titleAnti‐ganglioside antibody induction by swine (a/nj/1976/h1n1) and other influenza vaccines: insights into vaccine‐associated guillain‐barré syndrome
dc.typeArticle
dc.identifier.doi10.1086/589624
dc.local.publishedsourcehttps://academic.oup.com/jid/article-pdf/198/2/226/18054112/198-2-226.pdf
nui.item.downloads0


Files in this item

This item appears in the following Collection(s)

Show simple item record